04/15/2024 4:15 PM | SAB Biotherapeutics, Inc. (Filer) SAB Biotherapeutics (Filer) SAB Biotherapeutics, Inc. (Filer)
| Form 8-K Current report pursuant to Section 13 or 15(d) | |
03/29/2024 8:35 AM | SAB Biotherapeutics, Inc. (Filer) SAB Biotherapeutics (Filer) SAB Biotherapeutics, Inc. (Filer)
| Form 8-K Current report pursuant to Section 13 or 15(d) | |
02/23/2024 3:50 PM | Bausch Christoph Lawrence (Reporting) SAB Biotherapeutics, Inc. (Issuer) SAB Biotherapeutics (Issuer) SAB Biotherapeutics, Inc. (Issuer)
| Form 4 Statement of changes in beneficial ownership of securities | |
02/23/2024 3:55 PM | SAB Biotherapeutics, Inc. (Issuer) SAB Biotherapeutics (Issuer) SAB Biotherapeutics, Inc. (Issuer) Sullivan Eddie Joe (Reporting)
| Form 4 Statement of changes in beneficial ownership of securities | |
02/23/2024 4:00 PM | Kropotova Alexandra (Reporting) SAB Biotherapeutics, Inc. (Issuer) SAB Biotherapeutics (Issuer) SAB Biotherapeutics, Inc. (Issuer)
| Form 4 Statement of changes in beneficial ownership of securities | |
02/23/2024 3:40 PM | Reich Samuel J (Reporting) SAB Biotherapeutics, Inc. (Issuer) SAB Biotherapeutics (Issuer) SAB Biotherapeutics, Inc. (Issuer)
| Form 4 Statement of changes in beneficial ownership of securities | |
02/14/2024 6:02 AM | RTW INVESTMENTS, LP (Filed by) SAB Biotherapeutics, Inc. (Subject) SAB Biotherapeutics (Subject) SAB Biotherapeutics, Inc. (Subject)
| Form SC 13G | |
|
02/14/2024 5:28 AM | Radcliffe Capital Management, L.P. (Filed by) SAB Biotherapeutics, Inc. (Subject) SAB Biotherapeutics (Subject) SAB Biotherapeutics, Inc. (Subject)
| Form SC 13G/A | |
02/02/2024 6:53 AM | SAB Biotherapeutics, Inc. (Filer) SAB Biotherapeutics (Filer) SAB Biotherapeutics, Inc. (Filer)
| Form 8-K Current report pursuant to Section 13 or 15(d) | |
01/26/2024 3:00 PM | SAB Biotherapeutics, Inc. (Filer) SAB Biotherapeutics (Filer) SAB Biotherapeutics, Inc. (Filer) SAB Biotherapeutics, Inc. (Filer) SAB Biotherapeutics (Filer) SAB Biotherapeutics, Inc. (Filer)
| Form 424B5 | |
01/25/2024 4:00 PM | SAB Biotherapeutics, Inc. (Filer) SAB Biotherapeutics (Filer) SAB Biotherapeutics, Inc. (Filer)
| Form 8-K Current report pursuant to Section 13 or 15(d) | |
01/19/2024 3:21 PM | SAB Biotherapeutics, Inc. (Filer) SAB Biotherapeutics (Filer) SAB Biotherapeutics, Inc. (Filer)
| Form 8-K Current report pursuant to Section 13 or 15(d) | |
01/03/2024 8:00 AM | SAB Biotherapeutics, Inc. (Filer) SAB Biotherapeutics (Filer) SAB Biotherapeutics, Inc. (Filer)
| Form 8-K Current report pursuant to Section 13 or 15(d) | |
12/18/2023 8:34 AM | SAB Biotherapeutics, Inc. (Filer) SAB Biotherapeutics (Filer) SAB Biotherapeutics, Inc. (Filer)
| Form DEF 14A | |
12/08/2023 4:26 PM | SAB Biotherapeutics, Inc. (Filer) SAB Biotherapeutics (Filer) SAB Biotherapeutics, Inc. (Filer)
| Form PRE 14A | |
12/08/2023 7:00 AM | SAB Biotherapeutics, Inc. (Issuer) SAB Biotherapeutics (Issuer) SAB Biotherapeutics, Inc. (Issuer) SAB Biotherapeutics, Inc. (Issuer) SAB Biotherapeutics (Issuer) SAB Biotherapeutics, Inc. (Issuer) Sullivan Eddie Joe (Reporting) Sullivan Eddie Joe (Reporting)
| Form 4 Statement of changes in beneficial ownership of securities | |
12/04/2023 3:33 PM | BIOTECHNOLOGY VALUE FUND L P (Filed by) SAB Biotherapeutics, Inc. (Subject) SAB Biotherapeutics (Subject) SAB Biotherapeutics, Inc. (Subject)
| Form SC 13G | |
11/30/2023 4:00 PM | King Michael (Reporting) SAB Biotherapeutics, Inc. (Issuer) SAB Biotherapeutics (Issuer) SAB Biotherapeutics, Inc. (Issuer)
| Form 4 Statement of changes in beneficial ownership of securities | |
11/30/2023 7:00 AM | Reich Samuel J (Reporting) SAB Biotherapeutics, Inc. (Issuer) SAB Biotherapeutics (Issuer) SAB Biotherapeutics, Inc. (Issuer)
| Form 4 Statement of changes in beneficial ownership of securities | |
11/29/2023 6:40 AM | SAB Biotherapeutics, Inc. (Filer) SAB Biotherapeutics (Filer) SAB Biotherapeutics, Inc. (Filer)
| Form 8-K Current report pursuant to Section 13 or 15(d) | |
11/28/2023 11:15 PM | SAB Biotherapeutics, Inc. (Filer) SAB Biotherapeutics (Filer) SAB Biotherapeutics, Inc. (Filer)
| Form EFFECT | |
11/22/2023 3:45 PM | SAB Biotherapeutics, Inc. (Filer) SAB Biotherapeutics (Filer) SAB Biotherapeutics, Inc. (Filer)
| Form 8-K Current report pursuant to Section 13 or 15(d) | |
11/22/2023 3:30 PM | Ellias Helen K. (Reporting) SAB Biotherapeutics, Inc. (Issuer) SAB Biotherapeutics (Issuer) SAB Biotherapeutics, Inc. (Issuer)
| Form 3 Initial statement of beneficial ownership of securities | |
11/20/2023 3:45 PM | SAB Biotherapeutics, Inc. (Filer) SAB Biotherapeutics (Filer) SAB Biotherapeutics, Inc. (Filer)
| Form S-3/A | |
11/15/2023 8:10 PM | Moin Andrew (Reporting) SAB Biotherapeutics, Inc. (Issuer) SAB Biotherapeutics (Issuer) SAB Biotherapeutics, Inc. (Issuer)
| Form 4/A | |
11/15/2023 3:30 PM | Petry John (Reporting) SAB Biotherapeutics, Inc. (Issuer) SAB Biotherapeutics (Issuer) SAB Biotherapeutics, Inc. (Issuer) Sessa Capital , L.P. (0001618360) (Reporting) Sessa Capital GP, LLC (Reporting) Sessa Capital IM GP, LLC (Reporting) Sessa Capital IM, L.P. (Reporting)
| Form 4/A | |
11/14/2023 6:00 PM | Moin Andrew (Reporting) SAB Biotherapeutics, Inc. (Issuer) SAB Biotherapeutics (Issuer) SAB Biotherapeutics, Inc. (Issuer)
| Form 4 Statement of changes in beneficial ownership of securities | |
11/03/2023 3:50 PM | King Michael (Reporting) SAB Biotherapeutics, Inc. (Issuer) SAB Biotherapeutics (Issuer) SAB Biotherapeutics, Inc. (Issuer)
| Form 4 Statement of changes in beneficial ownership of securities | |
11/03/2023 4:00 PM | SAB Biotherapeutics, Inc. (Filer) SAB Biotherapeutics (Filer) SAB Biotherapeutics, Inc. (Filer)
| Form S-3 Registration statement under Securities Act of 1933 | |
11/03/2023 3:40 PM | King Michael (Reporting) SAB Biotherapeutics, Inc. (Issuer) SAB Biotherapeutics (Issuer) SAB Biotherapeutics, Inc. (Issuer)
| Form 3 Initial statement of beneficial ownership of securities | |
10/27/2023 4:00 PM | SAB Biotherapeutics, Inc. (Filer) SAB Biotherapeutics (Filer) SAB Biotherapeutics, Inc. (Filer)
| Form 8-K Current report pursuant to Section 13 or 15(d) | |
10/24/2023 4:30 PM | Moin Andrew (Reporting) SAB Biotherapeutics, Inc. (Issuer) SAB Biotherapeutics (Issuer) SAB Biotherapeutics, Inc. (Issuer)
| Form 4 Statement of changes in beneficial ownership of securities | |
10/24/2023 4:33 PM | Petry John (Reporting) SAB Biotherapeutics, Inc. (Issuer) SAB Biotherapeutics (Issuer) SAB Biotherapeutics, Inc. (Issuer) Sessa Capital , L.P. (0001618360) (Reporting) Sessa Capital GP, LLC (Reporting) Sessa Capital IM GP, LLC (Reporting) Sessa Capital IM, L.P. (Reporting)
| Form 4 Statement of changes in beneficial ownership of securities | |
10/20/2023 3:30 PM | SAB Biotherapeutics, Inc. (Filer) SAB Biotherapeutics (Filer) SAB Biotherapeutics, Inc. (Filer)
| Form PRE 14A | |
10/16/2023 3:05 PM | COMMODORE CAPITAL LP (Filed by) SAB Biotherapeutics, Inc. (Subject) SAB Biotherapeutics (Subject) SAB Biotherapeutics, Inc. (Subject)
| Form SC 13G | |
10/16/2023 3:08 PM | SAB Biotherapeutics, Inc. (Filer) SAB Biotherapeutics (Filer) SAB Biotherapeutics, Inc. (Filer)
| Form D Notice of Exempt Offering of Securities | |
10/10/2023 3:24 PM | Petry John (Reporting) SAB Biotherapeutics, Inc. (Issuer) SAB Biotherapeutics (Issuer) SAB Biotherapeutics, Inc. (Issuer) Sessa Capital , L.P. (0001618360) (Reporting) Sessa Capital GP, LLC (Reporting) Sessa Capital IM GP, LLC (Reporting) Sessa Capital IM, L.P. (Reporting)
| Form 3 Initial statement of beneficial ownership of securities | |
08/30/2023 11:15 PM | SAB Biotherapeutics, Inc. (Filer) SAB Biotherapeutics (Filer) SAB Biotherapeutics, Inc. (Filer)
| Form EFFECT | |
08/21/2023 3:15 PM | SAB Biotherapeutics, Inc. (Filer) SAB Biotherapeutics (Filer) SAB Biotherapeutics, Inc. (Filer)
| Form S-3 Registration statement under Securities Act of 1933 | |
08/21/2023 7:25 AM | SAB Biotherapeutics, Inc. (Filer) SAB Biotherapeutics (Filer) SAB Biotherapeutics, Inc. (Filer)
| Form 8-K Current report pursuant to Section 13 or 15(d) | |
08/21/2023 7:23 AM | SAB Biotherapeutics, Inc. (Filer) SAB Biotherapeutics (Filer) SAB Biotherapeutics, Inc. (Filer)
| Form 10-Q General form for quarterly reports under Section 13 or 15(d) | |
This 1 Biotech Stock has been shocking the markets (Ad) Save the Date: BioStem's 2024 Q1 Call Coming Up! Sign Up for the Live Broadcast here |
07/31/2023 3:43 PM | SAB Biotherapeutics, Inc. (Filer) SAB Biotherapeutics (Filer) SAB Biotherapeutics, Inc. (Filer)
| Form 8-K Current report pursuant to Section 13 or 15(d) | |
07/10/2023 4:19 PM | SAB Biotherapeutics, Inc. (Filer) SAB Biotherapeutics (Filer) SAB Biotherapeutics, Inc. (Filer)
| Form POS AM | |
07/03/2023 12:20 PM | SAB Biotherapeutics, Inc. (Filer) SAB Biotherapeutics (Filer) SAB Biotherapeutics, Inc. (Filer)
| Form 8-K Current report pursuant to Section 13 or 15(d) | |
06/21/2023 3:05 PM | SAB Biotherapeutics, Inc. (Filer) SAB Biotherapeutics (Filer) SAB Biotherapeutics, Inc. (Filer)
| Form RW | |
06/21/2023 7:50 AM | SAB Biotherapeutics, Inc. (Filer) SAB Biotherapeutics (Filer) SAB Biotherapeutics, Inc. (Filer)
| Form 8-K Current report pursuant to Section 13 or 15(d) | |
06/14/2023 7:53 AM | SAB Biotherapeutics, Inc. (Filer) SAB Biotherapeutics (Filer) SAB Biotherapeutics, Inc. (Filer)
| Form 8-K Current report pursuant to Section 13 or 15(d) | |
05/19/2023 8:29 AM | SAB Biotherapeutics, Inc. (Filer) SAB Biotherapeutics (Filer) SAB Biotherapeutics, Inc. (Filer)
| Form DEF 14A | |
05/17/2023 11:15 PM | SAB Biotherapeutics, Inc. (Filer) SAB Biotherapeutics (Filer) SAB Biotherapeutics, Inc. (Filer)
| Form EFFECT | |
05/09/2023 11:15 PM | SAB Biotherapeutics, Inc. (Filer) SAB Biotherapeutics (Filer) SAB Biotherapeutics, Inc. (Filer)
| Form EFFECT | |